Evidence map›Paper›PMID 35995049›Full record

ReviewAnnual review of nutrition2022

Dietary Fructose and Fructose-Induced Pathologies.

Sunhee Jung, Hosung Bae, Won-Suk Song, Cholsoon Jang

Open access · greenAbstract readReview
In one paragraph

Review in Annual review of nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 4 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 4 syntheses or guidelines pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Differential Effects ofNutrients · 2026
    Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Sunhee JungDepartment of Biological Chemistry, University of California, Irvine, California, USA; email: sunheej2@hs.uci.edu, hosungb@hs.uci.edu, wonsus1@hs.uci.edu, choljang@uci.edu.
Hosung BaeDepartment of Biological Chemistry, University of California, Irvine, California, USA; email: sunheej2@hs.uci.edu, hosungb@hs.uci.edu, wonsus1@hs.uci.edu, choljang@uci.edu.
Won-Suk SongDepartment of Biological Chemistry, University of California, Irvine, California, USA; email: sunheej2@hs.uci.edu, hosungb@hs.uci.edu, wonsus1@hs.uci.edu, choljang@uci.edu.
Cholsoon JangDepartment of Biological Chemistry, University of California, Irvine, California, USA; email: sunheej2@hs.uci.edu, hosungb@hs.uci.edu, wonsus1@hs.uci.edu, choljang@uci.edu.
University of California, Irvine · US

Funding

Elucidating dietary fructose and alcohol interactions during liver cancer developmentR01AA029124 · NIAAA · UNIVERSITY OF CALIFORNIA-IRVINE · PI JANG, CHOLSOON · 2021 to 2025
$2.0M
NIAAA NIH HHS R01 AA029124
6 · The paper itself

Abstract

The consumption of fructose as sugar and high-fructose corn syrup has markedly increased during the past several decades. This trend coincides with the exponential rise of metabolic diseases, including obesity, nonalcoholic fatty liver disease, cardiovascular disease, and diabetes. While the biochemical pathways of fructose metabolism were elucidated in the early 1990s, organismal-level fructose metabolism and its whole-body pathophysiological impacts have been only recently investigated. In this review, we discuss the history of fructose consumption, biochemical and molecular pathways involved in fructose metabolism in different organs and gut microbiota, the role of fructose in the pathogenesis of metabolic diseases, and the remaining questions to treat such diseases.

Indexed as

High Fructose Corn SyrupMetabolic DiseasesNon-alcoholic Fatty Liver DiseaseDietFructoseHumansLiverFructoseHigh Fructose Corn Syrupfatty liverfructosegut microbiotaintestineketohexokinaselipogenesis

Identifiers

PMID35995049
PMCPMC9904196
OpenAlexW4293276412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.